Brain tumor drug study pulled before enrolling a single patient
NCT ID NCT06012929
First seen Jan 27, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study aimed to test the drug ONC201 in people with a type of brain tumor called meningioma that had come back or wasn't responding to other treatments. It planned to measure how much drug gets into the tumor during surgery and how long patients lived without their tumor getting worse. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.